Metadoxine Approval Status
FDA Approved: No
Generic name: metadoxine
Company: Alcobra Ltd.
Treatment for: ADHD
Metadoxine is an ion-pair salt of pyridoxine (vitamin B6) in development for the treatment of Attention Deficit/Hyperactivity Disorder (ADHD).
Development Status and FDA Approval Process for metadoxine
|Jan 9, 2017||Alcobra Provides Update on Recent FDA Meeting and Path Forward for MDX Clinical Development Program|
|Feb 7, 2014||Alcobra Announces IND Submission for Extended Release Metadoxine to Treat Adults With ADHD|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.